Sai Parenteral Shares List at Premium Despite Weak Market Sentiment
New Delhi, April 2: Shares of Sai Parenteral, a diversified pharmaceutical formulation company, made a positive stock market debut on Thursday, listing at a premium of over 3 percent compared to its issue price, even as broader markets remained under pressure.Stock Lists Above Issue Price on BSE and NSE
The stock opened at Rs 405 on the BSE, reflecting a gain of 3.32 percent over its issue price of Rs 392. On the NSE, shares debuted at Rs 400, marking a 2.04 percent increase.Following the listing, the company’s market valuation stood at Rs 1,784.84 crore on the NSE.Listing Amid Broad Market Weakness
Sai Parenteral’s listing comes at a time when domestic equity...